Skip to main content
Erschienen in: World Journal of Surgery 8/2009

01.08.2009

Superficial Soft Tissue Sarcomas of the Extremities and Trunk

verfasst von: Anja Lachenmayer, Qin Yang, Claus F. Eisenberger, Edwin Boelke, Christopher Poremba, Antje Heinecke, Christian Ohmann, Wolfram Trudo Knoefel, Matthias Peiper

Erschienen in: World Journal of Surgery | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Superficial soft tissue sarcomas (sSTS) are an important and frequent subtype of soft tissue sarcoma (STS). A wider knowledge of this tumor type may lead to better strategies in tumor therapy.

Methods

An institutional review was performed on all patients with primary sSTS of the extremities and trunk operated on between 1990 and 2003.

Results

The medical records of 108 patients with sSTS were analyzed. The local recurrence rate was 11% after a median of 25 (mean 42) months. Metastases occurred in 21 patients (19%), and 79 patients lived without evidence of disease after a mean follow-up of 112 ± 42 months. Mean survival time was 89 months at a cumulative 5-year survival rate of 85%. R0 resection significantly enhanced cumulative survival (p = .001), as did patient age < 60 years (p = .002), tumor grading G1 and G2 compared to G3 (p = .004), absence of positive lymph nodes (p = .018), and no occurrence of metastases (p = .001). Tumor size ≤ 5 cm reduced the local recurrence rate significantly (p = .044). Significant multivariate risk factors for metastases were age ≥ 60 years (p = .016) and tumor grade G3 (p = .021).

Conclusions

Patients with sSTS who are ≥60 years of age or who have G3 tumors have a high risk of distant metastases. Patients with T2 tumors have an elevated risk for local recurrence. Certainly all patients with sSTS should be in a tight after-care program to allow early diagnosis of local recurrence or distant metastases. Age < 60 years, tumor grade G1/2, no positive regional lymph nodes (N0), and a R0 resection are significant prognostic factors for survival.
Literatur
1.
Zurück zum Zitat Singer S, Demetri GD, Baldini EH et al (2000) Management of soft-tissue sarcomas: an overview and update. Lancet Oncol 1:75–85PubMedCrossRef Singer S, Demetri GD, Baldini EH et al (2000) Management of soft-tissue sarcomas: an overview and update. Lancet Oncol 1:75–85PubMedCrossRef
2.
Zurück zum Zitat National Cancer Institute, Surveillance, Epidemiology, and End Results Program (SEER), 1973–2000 National Cancer Institute, Surveillance, Epidemiology, and End Results Program (SEER), 1973–2000
3.
Zurück zum Zitat Nedea EA, DeLaney TF (2006) Sarcoma and skin radiation oncology. Hematol Oncol Clin North Am 20:401–429PubMedCrossRef Nedea EA, DeLaney TF (2006) Sarcoma and skin radiation oncology. Hematol Oncol Clin North Am 20:401–429PubMedCrossRef
4.
Zurück zum Zitat Hermanek P, Seib HJ, Wittekind C (1997) Current TNM classification. 4. Residual tumor–classification. Commissioned by the German Speaking TNM Committee. Zentralbl Chir 122:52–55PubMed Hermanek P, Seib HJ, Wittekind C (1997) Current TNM classification. 4. Residual tumor–classification. Commissioned by the German Speaking TNM Committee. Zentralbl Chir 122:52–55PubMed
5.
Zurück zum Zitat NIH (National Institutes of Health, US) Adult soft tissue sarcoma treatment (PDQ®) NIH (National Institutes of Health, US) Adult soft tissue sarcoma treatment (PDQ®)
6.
Zurück zum Zitat Pijpe J, Broers GH, Plaat BE et al (2002) The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma. Sarcoma 6:105–110PubMedCrossRef Pijpe J, Broers GH, Plaat BE et al (2002) The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma. Sarcoma 6:105–110PubMedCrossRef
7.
Zurück zum Zitat Svarvar C, Böhling T, Berlin O et al. for the Scandinavian Sarcoma Group—Leiomyosarcoma Working Group (2007) Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group. Cancer 109:282–291 Svarvar C, Böhling T, Berlin O et al. for the Scandinavian Sarcoma Group—Leiomyosarcoma Working Group (2007) Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group. Cancer 109:282–291
8.
Zurück zum Zitat Peabody TD, Monson D, Montag A et al (1994) A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities. J Bone Joint Surg Am 76:1167–1173PubMed Peabody TD, Monson D, Montag A et al (1994) A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities. J Bone Joint Surg Am 76:1167–1173PubMed
9.
Zurück zum Zitat Dickinson IC, Whitwell DJ, Battistuta D et al (2006) Surgical margin and its influence on survival in soft tissue sarcoma. Aust N Z J Surg 76:104–109CrossRef Dickinson IC, Whitwell DJ, Battistuta D et al (2006) Surgical margin and its influence on survival in soft tissue sarcoma. Aust N Z J Surg 76:104–109CrossRef
10.
Zurück zum Zitat Kiatisevi P, Asavamongkolkul A, Phimolsarnti R et al (2006) The outcomes and prognostic factors of patients with soft-tissue sarcoma. J Med Assoc Thai 89:334–342PubMed Kiatisevi P, Asavamongkolkul A, Phimolsarnti R et al (2006) The outcomes and prognostic factors of patients with soft-tissue sarcoma. J Med Assoc Thai 89:334–342PubMed
11.
Zurück zum Zitat Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305–315PubMedCrossRef Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305–315PubMedCrossRef
12.
Zurück zum Zitat de Stefani E, Deneo-Pellegrini H, Carzoglio J et al (1982) Soft tissue sarcoma: histologic factors of prognosis. Bull Cancer 69:443–450PubMed de Stefani E, Deneo-Pellegrini H, Carzoglio J et al (1982) Soft tissue sarcoma: histologic factors of prognosis. Bull Cancer 69:443–450PubMed
13.
Zurück zum Zitat Mettlin C, Priore R, Rao U et al (1982) Results of the national soft-tissue sarcoma registry. J Surg Oncol 19:224–227PubMedCrossRef Mettlin C, Priore R, Rao U et al (1982) Results of the national soft-tissue sarcoma registry. J Surg Oncol 19:224–227PubMedCrossRef
14.
Zurück zum Zitat Cahlon O, Spierer M, Brennan MF et al (2008) Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy. Cancer 112:2774–2779PubMedCrossRef Cahlon O, Spierer M, Brennan MF et al (2008) Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy. Cancer 112:2774–2779PubMedCrossRef
15.
Zurück zum Zitat McKee MD, Liu DF, Brooks JJ et al (2004) The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 85:68–76PubMedCrossRef McKee MD, Liu DF, Brooks JJ et al (2004) The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 85:68–76PubMedCrossRef
16.
Zurück zum Zitat Pezzi CM, Rawlings MS Jr, Esgro JJ et al (1992) Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 69:2098–2103PubMedCrossRef Pezzi CM, Rawlings MS Jr, Esgro JJ et al (1992) Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 69:2098–2103PubMedCrossRef
17.
Zurück zum Zitat Rougraff BT, Davis K, Cudahy T (2005) The impact of previous surgical manipulation of 5 subcutaneous sarcoma on oncologic outcome. Clin Orthop Relat Res 438:85–91PubMedCrossRef Rougraff BT, Davis K, Cudahy T (2005) The impact of previous surgical manipulation of 5 subcutaneous sarcoma on oncologic outcome. Clin Orthop Relat Res 438:85–91PubMedCrossRef
18.
Zurück zum Zitat Rydholm A, Gustafson P (2003) Should tumor depth be included in prognostication of soft tissue sarcoma? BMC Cancer 3:17PubMedCrossRef Rydholm A, Gustafson P (2003) Should tumor depth be included in prognostication of soft tissue sarcoma? BMC Cancer 3:17PubMedCrossRef
19.
Zurück zum Zitat Peiper M, Zurakowski D, Schwarz R et al (1998) Survival in patients with primary soft-tissue sarcomas treated within 6 years. J Cancer Res Clin Oncol 124:199–206PubMedCrossRef Peiper M, Zurakowski D, Schwarz R et al (1998) Survival in patients with primary soft-tissue sarcomas treated within 6 years. J Cancer Res Clin Oncol 124:199–206PubMedCrossRef
20.
Zurück zum Zitat Peiper M, Knoefel WT, Izbicki JR (2004) The influence of residual tumor on local recurrence after unplanned resection of soft tissue sarcoma. Dtsch Med Wochenschr 129:183–187PubMedCrossRef Peiper M, Knoefel WT, Izbicki JR (2004) The influence of residual tumor on local recurrence after unplanned resection of soft tissue sarcoma. Dtsch Med Wochenschr 129:183–187PubMedCrossRef
21.
Zurück zum Zitat Peiper M, Zurakowski D, Zornig C (1995) Local recurrence of soft tissue sarcoma of the extremities and trunk. Langenbecks Arch Chir 380:333–339PubMedCrossRef Peiper M, Zurakowski D, Zornig C (1995) Local recurrence of soft tissue sarcoma of the extremities and trunk. Langenbecks Arch Chir 380:333–339PubMedCrossRef
22.
23.
Zurück zum Zitat Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859–868PubMed Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859–868PubMed
24.
Zurück zum Zitat Rydholm A, Gustafson P, Rooser B et al (1991) Subcutaneous sarcoma. A population-based study of 129 patients. J Bone Joint Surg Br 73:662–667PubMed Rydholm A, Gustafson P, Rooser B et al (1991) Subcutaneous sarcoma. A population-based study of 129 patients. J Bone Joint Surg Br 73:662–667PubMed
25.
Zurück zum Zitat Brennan MF, Hilaris B, Shiu MH et al (1987) Local recurrence in adult soft-tissue sarcoma. A randomized trial of brachytherapy. Arch Surg 122:1289–1293PubMed Brennan MF, Hilaris B, Shiu MH et al (1987) Local recurrence in adult soft-tissue sarcoma. A randomized trial of brachytherapy. Arch Surg 122:1289–1293PubMed
26.
Zurück zum Zitat Yang JC, Chang AE, Baker AR et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197–203PubMed Yang JC, Chang AE, Baker AR et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197–203PubMed
27.
Zurück zum Zitat Bujko K, Suit HD, Springfield DS et al (1993) Wound healing after preoperative radiation for sarcoma of soft tissues. Surg Gynecol Obstet 176:124–134PubMed Bujko K, Suit HD, Springfield DS et al (1993) Wound healing after preoperative radiation for sarcoma of soft tissues. Surg Gynecol Obstet 176:124–134PubMed
28.
Zurück zum Zitat Frezza G, Barbieri E, Ammendolia I et al (1992) Surgery and radiation therapy in the treatment of soft tissue sarcomas of extremities. Ann Oncol 3(Suppl 2):S93–S95PubMed Frezza G, Barbieri E, Ammendolia I et al (1992) Surgery and radiation therapy in the treatment of soft tissue sarcomas of extremities. Ann Oncol 3(Suppl 2):S93–S95PubMed
29.
Zurück zum Zitat Saddegh MK, Lindholm J, Lundberg A et al (1992) Staging of soft-tissue sarcomas. Prognostic analysis of clinical and pathological features. J Bone Joint Surg Br 74:495–500PubMed Saddegh MK, Lindholm J, Lundberg A et al (1992) Staging of soft-tissue sarcomas. Prognostic analysis of clinical and pathological features. J Bone Joint Surg Br 74:495–500PubMed
30.
Zurück zum Zitat Riad S, Griffin AM, Liberman B et al (2004) Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426:129–134PubMedCrossRef Riad S, Griffin AM, Liberman B et al (2004) Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426:129–134PubMedCrossRef
31.
Zurück zum Zitat Behranwala KA, A’Hern R, Omar AM et al (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719PubMedCrossRef Behranwala KA, A’Hern R, Omar AM et al (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719PubMedCrossRef
32.
Zurück zum Zitat Kaytan E, Yaman F, Cosar R et al (2003) Prognostic factors in localized soft-tissue sarcomas. Am J Clin Oncol 26:411–415PubMedCrossRef Kaytan E, Yaman F, Cosar R et al (2003) Prognostic factors in localized soft-tissue sarcomas. Am J Clin Oncol 26:411–415PubMedCrossRef
33.
Zurück zum Zitat Stojadinovic A, Leung DH, Allen P et al (2002) Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol 20:4344–4352PubMedCrossRef Stojadinovic A, Leung DH, Allen P et al (2002) Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol 20:4344–4352PubMedCrossRef
34.
Zurück zum Zitat Heise HW, Myers MH, Russell WO et al (1986) Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 57:172–177PubMedCrossRef Heise HW, Myers MH, Russell WO et al (1986) Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 57:172–177PubMedCrossRef
35.
Zurück zum Zitat Berlin O, Stener B, Angervall L et al (1990) Surgery for soft tissue sarcoma in the extremities. A multivariate analysis of the 6–26-year prognosis in 137 patients. Acta Orthop Scand 61:475–486PubMedCrossRef Berlin O, Stener B, Angervall L et al (1990) Surgery for soft tissue sarcoma in the extremities. A multivariate analysis of the 6–26-year prognosis in 137 patients. Acta Orthop Scand 61:475–486PubMedCrossRef
36.
Zurück zum Zitat Gibbs JF, Huang PP, Lee RJ et al (2001) Malignant fibrous histiocytoma: an institutional review. Cancer Invest 19:23–27PubMedCrossRef Gibbs JF, Huang PP, Lee RJ et al (2001) Malignant fibrous histiocytoma: an institutional review. Cancer Invest 19:23–27PubMedCrossRef
Metadaten
Titel
Superficial Soft Tissue Sarcomas of the Extremities and Trunk
verfasst von
Anja Lachenmayer
Qin Yang
Claus F. Eisenberger
Edwin Boelke
Christopher Poremba
Antje Heinecke
Christian Ohmann
Wolfram Trudo Knoefel
Matthias Peiper
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 8/2009
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0051-1

Weitere Artikel der Ausgabe 8/2009

World Journal of Surgery 8/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.